Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000232906 (LOC100533634) is annotated as a novel pseudogene that contains sequence homology to the *C2H2-type zinc finger domain*, a structural motif found in one of the largest families of eukaryotic transcription factors[1][6][5]. The C2H2-type zinc finger domain is characterized by a conserved beta-beta-alpha structure stabilized by a zinc atom bound by two cysteines and two histidines[2][5]. While active C2H2 zinc finger proteins can bind DNA, RNA, or protein and regulate gene transcription, LOC100533634 is annotated as a *pseudogene*, meaning it is not believed to code for a functional protein product and has no described biological or clinical function, no role in disease, and is not pursued as a drug target[1].
None (no drugs target this pseudogene; thus, no mechanism of action relevant)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel pseudogene containing a Zinc finger, C2H2 type domain (LOC100533634).